BCL2L1 and central nervous system cancer: Immune-related genes GZMB, HLA-A and BCL2L1 were significantly over-expressed in high-grade glioma patients (p < 0.001, versus low-grade glioma patients) and a concordance between differentially expressed genes in plasma- and glioma-derived RNA was reported.